Compare ABM & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABM | TMDX |
|---|---|---|
| Founded | 1909 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.4B |
| IPO Year | 1994 | 2019 |
| Metric | ABM | TMDX |
|---|---|---|
| Price | $44.40 | $71.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $47.80 | ★ $148.22 |
| AVG Volume (30 Days) | 764.2K | ★ 1.1M |
| Earning Date | 06-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.92% | N/A |
| EPS Growth | 102.34 | ★ 382.18 |
| EPS | ★ 1.37 | 0.20 |
| Revenue | ★ $8,745,900,000.00 | $605,494,000.00 |
| Revenue This Year | $5.97 | $24.25 |
| Revenue Next Year | $3.45 | $18.75 |
| P/E Ratio | ★ $32.31 | $344.30 |
| Revenue Growth | 4.62 | ★ 37.13 |
| 52 Week Low | $36.96 | $60.11 |
| 52 Week High | $50.12 | $156.00 |
| Indicator | ABM | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 59.28 | 49.10 |
| Support Level | $44.50 | $64.90 |
| Resistance Level | $46.53 | $80.72 |
| Average True Range (ATR) | 1.18 | 3.96 |
| MACD | -0.12 | -0.03 |
| Stochastic Oscillator | 59.06 | 48.79 |
ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.